PrEP and PEP are important HIV prevention tools that hospitalists should understand and discuss with patients during hospital ...

Federal money is at risk for programs to prevent and treat HIV. In Washington, lawmakers are considering cuts for the next ...

The Lenacapavir injections were compared to the current standard of HIV prevention—a pill called Truvada or Descovy taken ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced positive data from two late-stage studies, ISLEND-1 and ISLEND-2, ...

3 Blue-Chip Stocks Built for a Rotating Market Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined several upcoming clinical and regulatory priorities across oncology, ...

After failing for the second year in a row to pass a budget on time, the Florida Legislature has cobbled together this year’s ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults with chronic hepatitis delta virus (HDV) infection. The approval makes ...

But with GLP-1 drugs, she said, “everyone is kind of iterating in real time.” Here’s what we’ve learned in the process. At ...

A new look at data from a nationally representative survey finds that more than 8 million people, roughly 2.8% of the U.S.

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...

GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...